Advances in Rapid Sex-Steroid Action

Breast and prostate cancers are both hormone-dependent, at least in some stages of their progression. The immediate challenge is the dissection of key events regulating the steroid response of target tissues to prevent progression and improve treatment of breast and prostate cancers.